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Cytotoxicity and immunomodulatory effects of damnacanthal and nordamnacanthal 
isolated from roots of morinda elliptica. 
 
ABSTRACT 
Morinda elliptica has been used traditionally as a medicine to treat various diseases in 
Malaysia and Southeast Asia. In this present study, the cytotoxicity and immunomodulatory 
effects of damnacanthal and nordamnacanthal isolated from the roots of Morinda elliptica 
were studied. Cytotoxic study was performed on human leukemia cell lines (HL-60) and 
mouse myelomonocyte leukemia (Wehi-3B) cell line, whereas immunomodulatory effect was 
evaluated by using lymphocytes proliferation assay on mice thymocytes and human 
peripheral blood mononuclear cells (PBMC). The production of extracellular human 
interleukin-2 (IL-2) and human interleukin-12 (IL-12) were also assessed by using the 
enzyme-linked immunosorbent assay (ELISA). The results indicated that both damnacanthal 
and nordamnacanthal inhibited the proliferation of HL-60 cells with the IC50 of 4.0 µg/mL 
and 20 µg/mL, respectively, and were able to activate mice thymocytes and human peripheral 
blood mononuclear cells (PBMC) at low concentration (0.47 µg/mL). Moreover, the 
production of extracellular human interleukin-2 (IL-2) and human interleukin-12 (IL-12) 
from both compounds-activated PBMC were prominently upregulated after 24 hours and the 
concentration remained almost constant up to 72 hours. Based on the results, both 
damnacanthal and nordamnacanthal can be cytotoxic and immunomodulatory agents which 
have the potential in cancer treatment. 
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